Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
3 R study: renal outcome in renal ischemia: revascularisation or medical treatment
Autore:
Zuccala, A; Zucchelli, P; Campieri, C; Esposti, ED; Losito, A; Timio, M; Boero, R;
Indirizzi:
Italian Soc Nephrol, Ischem Nephropathy & Renovasc Hyptertens Study Gr, Bologna Malpighi, Italy Italian Soc Nephrol Bologna Malpighi Italy Gr, Bologna Malpighi, Italy
Titolo Testata:
JOURNAL OF NEPHROLOGY
fascicolo: 2, volume: 13, anno: 2000,
pagine: 106 - 109
SICI:
1121-8428(200003/04)13:2<106:3RSROI>2.0.ZU;2-0
Fonte:
ISI
Lingua:
ENG
Soggetto:
RANDOMIZED TRIAL; ARTERY STENOSIS; REGRESSION; DISEASE; ATHEROSCLEROSIS; NEPHROPATHY; ANGIOPLASTY; EVENTS;
Keywords:
renovascular hypertension; percutaneous renal angioplasties; palmaz stent; ischemic nephropathy;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
14
Recensione:
Indirizzi per estratti:
Indirizzo: Zuccala, A Malpighi Policl S Orsola, Div Nefrol & Dialisi, Via P Palagi 9,I-40138 Bologna, Italy Malpighi Policl S Orsola Via P Palagi 9 Bologna Italy I-40138
Citazione:
A. Zuccala et al., "3 R study: renal outcome in renal ischemia: revascularisation or medical treatment", J NEPHROL, 13(2), 2000, pp. 106-109

Abstract

Ischemic nephropathy refers to the kidney damage following stenosis or an obstructive lesion in the main kidney arteries. This disorder has been overlooked in the past and a more rational and specific use of clinical criteria, and the development of not very invasive techniques with a good diagnostic accuracy such as spiral CT angiography, NMR angiography and echo-colour-Doppler have improved our ability to identify these patients. It is therefore likely that, in the next few years, we will find ourselves treating an increasing number of patients with renovascular ischemic disorders. Transluminal angioplasty and, more recently, the use of endovascular stents, have led to a marked improvement in the treatment of stenoses and, together with vascular surgery, allow to treat almost all patients with this disorder. There is, however, a lack of prospective and controlled studies, which demonstrate the long term benefit of revascularization treatment, as compared with optimum conservative treatment in reducing cardiovascular mortality, cardiovascular events and preserving renal function. The Ischemic Nephropathy Study Group of the Italian Society of Nephrology has organized a prospective, controlled study over a period of three years,aimed at comparing the effect of revascularization versus medical therapy in 300 patients with renal artery stenosis, ranging between 50 and 90 per cent, who will be randomly assigned to the two treatments. End point will becardiovascular mortality and morbidity and need for renal replacement therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/09/20 alle ore 10:22:29